| 06/28 | PFIZER INC : JP Morgan sticks Neutral | MD |
| 06/27 | PFIZER INC : Barclays reiterates its Neutral rating | MD |
| 05/27 | PFIZER INC : Berenberg sticks Neutral | MD |
| 05/25 | PFIZER INC : Goldman Sachs reiterates its Neutral rating | MD |
| 05/23 | ANALYST RECOMMANDATIONS : AbbVie, Amgen, Caterpillar, HP, Nike... | |
| 05/19 | PFIZER INC : Berenberg sticks Neutral | MD |
| 05/17 | PFIZER INC : Barclays remains Neutral | MD |
| 05/04 | Morgan Stanley Adjusts Pfizer's Price Target to $52 from $55, Keeps Equalweight Rating | MT |
| 05/04 | Goldman Sachs Adjusts Price Target for Pfizer to $51 From $53, Maintains Neutral Rating | MT |
| 05/04 | Wells Fargo Adjusts Pfizer's Price Target to $55 from $60, Keeps Overweight Rating | MT |
| 05/04 | PFIZER INC : Goldman Sachs sticks Neutral | MD |
| 05/04 | PFIZER INC : Barclays sticks Neutral | MD |
| 05/03 | PFIZER INC : JP Morgan remains Neutral | MD |
| 04/22 | Berenberg Bank Adjusts Pfizer's Price Target to $50 From $54, Maintains Hold Rating | MT |
| 04/21 | PFIZER INC : Berenberg sticks Neutral | MD |
| 04/12 | Goldman Sachs Adjusts Price Target for Pfizer to $53 From $50, Maintains Neutral Rating | MT |
| 04/05 | Citigroup Adjusts Pfizer's Price Target to $57 From $46, Maintains Neutral Rating | MT |
| 02/17 | ANALYST RECOMMENDATIONS : Airbnb, Avis, Pfizer, Roblox, 3M... | |
| 02/10 | Morgan Stanley Adjusts Pfizer Price Target to $55 From $60, Maintains Equal Weight Rati.. | MT |
| 02/10 | Morgan Stanley Adjusts Pfizer's Price Target to $55 from $60, Adjusts Equalweight Ratin.. | MT |
| 02/10 | Mizuho Adjusts Pfizer's Price Target to $55 From $56, Maintains Neutral Rating | MT |
| 02/10 | ANALYST RECOMMENDATIONS : AIG, American Express, Gartner, Pfizer, Thomson Reuters... | |
| 02/09 | Wells Fargo Adjusts Pfizer's Price Target to $60 From $65, Reiterates Overweight Rating | MT |
| 02/09 | PFIZER INC : Goldman Sachs reaffirms its Neutral rating | MD |
| 02/09 | PFIZER INC : Barclays gives a Neutral rating | MD |
| 02/08 | PFIZER INC : Goldman Sachs reaffirms its Neutral rating | MD |
| 02/08 | PFIZER INC : JP Morgan gives a Neutral rating | MD |
| 01/14 | BMO Capital Adjusts Pfizer's Price Target to $76 From $60, Keeps Outperform Rating | MT |
| 01/11 | PFIZER INC : Barclays reiterates its Neutral rating | MD |
| 01/07 | Wells Fargo Adjusts Pfizer Price Target to $65 From $60, Maintains Overweight Rating | MT |
| 01/07 | PFIZER INC : Goldman Sachs sticks Neutral | MD |
| 01/05 | BofA Securities Upgrades Pfizer to Buy From Neutral, Adjusts Price Target to $70 From $.. | MT |
| 2021 | PFIZER INC : Barclays remains Neutral | MD |
| 2021 | PFIZER INC : Goldman Sachs gives a Neutral rating | MD |
| 2021 | PFIZER INC : Goldman Sachs drops its Sell rating | MD |
| 2021 | Goldman Sachs Analyst Starts Pfizer at Neutral With $51 Price Target | MT |
| 2021 | Atlantic Securities Adjusts Pfizer PT to $52 From $42, Maintains Neutral Rating | MT |
| 2021 | SVB Leerink Adjusts Price Target on Pfizer to $56 From $52, Maintains Market Perform Ra.. | MT |
| 2021 | PFIZER INC : Barclays reaffirms its Neutral rating | MD |
| 2021 | Credit Suisse Downgrades Arena Pharmaceuticals to Neutral from Outperform Following New.. | MT |
| 2021 | RBC Downgrades Arena Pharmaceuticals to Sector Perform From Outperform, Lifts Price Tar.. | MT |
| 2021 | Mizuho Adjusts Pfizer's Price Target to $56 From $44, Maintains Neutral Rating | MT |
| 2021 | Berenberg Bank Lifts Pfizer's Price Target to $54 From $47, Citing COVID Vaccine Demand.. | MT |
| 2021 | PFIZER INC : JP Morgan gives a Neutral rating | MD |
| 2021 | UBS Upgrades Pfizer to Buy From Neutral, Adjusts PT to $60 From $52 on Anticipated Paxl.. | MT |
| 2021 | PFIZER INC : Upgraded to Buy by UBS | MD |
| 2021 | PFIZER INC : Barclays remains Neutral | MD |
| 2021 | Barclays Adjusts Pfizer's Price Target to $54 From $44, Keeps Equalweight Rating | MT |
| 2021 | Wells Fargo Starts Pfizer at Overweight With $60 Price Target | MT |
| 2021 | ANALYST RECOMMENDATIONS : Best Buy, Beyond Meat, Booking, Merck, Pfizer... | |
| 2021 | PFIZER INC : JP Morgan reiterates its Neutral rating | MD |
| 2021 | Morgan Stanley Adjusts Pfizer's Price Target to $60 From $50, Maintains Equalweight Rat.. | MT |
| 2021 | JPMorgan Adjusts Pfizer's Price Target to $53 From $42, Reiterates Neutral Rating | MT |
| 2021 | Truist Securities Adjusts Pfizer's Price Target to $58 From $43, Reiterates Buy Rating | MT |
| 2021 | BMO Capital Starts Pfizer at Outperform With $60 Price Target | MT |
| 2021 | PFIZER INC : Barclays reiterates its Neutral rating | MD |
| 2021 | Independent Research Upgrades Pfizer to Buy from Hold, Adjusts Price Target to $54 from.. | MT |
| 2021 | ANALYST RECOMMENDATIONS : Beyond Meat, HSBC, Pfizer, The Home Depot, Walt Disney... | |
| 2021 | UBS Adjusts Pfizer PT to $52 From $39, Maintains Neutral Rating | MT |
| 2021 | PFIZER INC : JP Morgan sticks Neutral | MD |
| 2021 | ANALYST RECOMMENDATIONS : American Water, Chegg, Lyft, Pfizer, Qualcomm... | |
| 2021 | PFIZER INC : Gets a Neutral rating from Barclays | MD |
| 2021 | SVB Leerink Adjusts Pfizer's Price Target to $48 from $50, Keeps Market Perform Rating | MT |
| 2021 | PFIZER : Morgan Stanley Adjusts Price Target on Pfizer to $48 From $45, Maintains Equal-We.. | MT |
| 2021 | PFIZER : SVB Leerink Adjusts Pfizer PT to $50 From $49, Maintains Market Perform Rating | MT |
| 2021 | PFIZER : Cantor Fitzgerald Adjusts Pfizer's Price Target to $61 From $50.24, Reiterates Ov.. | MT |
| 2021 | PFIZER : Berenberg Bank Adjusts Pfizer PT to $47 From $43, Maintains Hold Rating | MT |
| 2021 | ANALYST RECOMMENDATIONS : Amazon, Barclays, Comcast, Next, Pfizer... | |
| 2021 | PFIZER : Goldman Sachs Adjusts Pfizer's Price Target to $48 From $44, Maintains Neutral Ra.. | MT |
| 2021 | PFIZER : SVB Leerink Adjusts Price Target on Pfizer to $49 From $47, Maintains Market Perf.. | MT |
| 2021 | PFIZER : Morgan Stanley Adjusts Price Target on Pfizer to $45 From $42, Maintains Equal-We.. | MT |
| 2021 | PFIZER INC : Goldman Sachs gives a Neutral rating | MD |
| 2021 | PFIZER INC : RBC sticks Neutral | MD |
| 2021 | PFIZER : Price Target From RBC Lifted to $44 From $43 as Firm Raises Vaccine Revenue Forec.. | MT |
| 2021 | ANALYST RECOMMENDATIONS : Anglo American, Pfizer, Rolls-Royce, Nike, Oatly... | |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
